Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/CVac> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- CVac abstract "CVac, short for ‘Cancer Vaccine’, is a prospective therapeutic cancer vaccine that was originally developed in Australia. CVac works by attaching an adjuvant, mannan, to the tumor cell surface protein MUC1, a glycoprotein commonly expressed on a variety of cancers. CVac is often compared to the cancer vaccine Provenge, which gained FDA approval in 2010.CVac was developed by the biotechnology company Prima BioMed (Nasdaq: PBMD) through to Phase II clinical studies between 2001 and 2015. After inconclusive clinical data in ovarian cancer 2013 and 2014, Prima announced in February 2015 that it had ceased recruiting into CVAc clinical studies and was seeking commercial partners for the product. Evidence from the CAN-003 Phase IIb study has suggested that the product may have utility in ovarian cancer patients in their second remission.".
- CVac wikiPageExternalLink 197.abstract.
- CVac wikiPageExternalLink primabiomed.com.au.
- CVac wikiPageExternalLink Abstracts?&vmview=abst_detail_view&confID=74&abstractID=48318.
- CVac wikiPageExternalLink 747473.
- CVac wikiPageExternalLink ovarian-cancer.
- CVac wikiPageID "35431425".
- CVac wikiPageLength "14655".
- CVac wikiPageOutDegree "42".
- CVac wikiPageRevisionID "669404037".
- CVac wikiPageWikiLink Adjuvant.
- CVac wikiPageWikiLink Alpharetta,_Georgia.
- CVac wikiPageWikiLink Austin_Hospital,_Melbourne.
- CVac wikiPageWikiLink Australia.
- CVac wikiPageWikiLink Biotechnology.
- CVac wikiPageWikiLink Burnet_Institute.
- CVac wikiPageWikiLink CA-125.
- CVac wikiPageWikiLink Cancer.
- CVac wikiPageWikiLink Category:Cancer.
- CVac wikiPageWikiLink Category:Vaccination.
- CVac wikiPageWikiLink Cell_(biology).
- CVac wikiPageWikiLink ClinicalTrials.gov.
- CVac wikiPageWikiLink Clinical_Cancer_Research.
- CVac wikiPageWikiLink Dubai_Health_Authority.
- CVac wikiPageWikiLink Epithelial.
- CVac wikiPageWikiLink Epithelium.
- CVac wikiPageWikiLink Ex_vivo.
- CVac wikiPageWikiLink Fraunhofer_Society.
- CVac wikiPageWikiLink Fusion_protein.
- CVac wikiPageWikiLink Germany.
- CVac wikiPageWikiLink Glutathione_S-transferase.
- CVac wikiPageWikiLink Glycoprotein.
- CVac wikiPageWikiLink Leipzig.
- CVac wikiPageWikiLink Leukapheresis.
- CVac wikiPageWikiLink MUC1.
- CVac wikiPageWikiLink Mannan.
- CVac wikiPageWikiLink NASDAQ.
- CVac wikiPageWikiLink Nasdaq.
- CVac wikiPageWikiLink Neoplasm.
- CVac wikiPageWikiLink Ovarian_cancer.
- CVac wikiPageWikiLink P-value.
- CVac wikiPageWikiLink P_value.
- CVac wikiPageWikiLink Pancreatic_cancer.
- CVac wikiPageWikiLink Prima_BioMed.
- CVac wikiPageWikiLink Progression-free_survival.
- CVac wikiPageWikiLink Protein.
- CVac wikiPageWikiLink Reverse_takeover.
- CVac wikiPageWikiLink Saxony.
- CVac wikiPageWikiLink Sipuleucel-T.
- CVac wikiPageWikiLink Statistical_significance.
- CVac wikiPageWikiLink Therapy.
- CVac wikiPageWikiLink Tumor.
- CVac wikiPageWikiLink Vaccine.
- CVac wikiPageWikiLinkText "CVac".
- CVac hasPhotoCollection CVac.
- CVac wikiPageUsesTemplate Template:Reflist.
- CVac subject Category:Cancer.
- CVac subject Category:Vaccination.
- CVac hypernym Vaccine.
- CVac type Drug.
- CVac comment "CVac, short for ‘Cancer Vaccine’, is a prospective therapeutic cancer vaccine that was originally developed in Australia. CVac works by attaching an adjuvant, mannan, to the tumor cell surface protein MUC1, a glycoprotein commonly expressed on a variety of cancers. CVac is often compared to the cancer vaccine Provenge, which gained FDA approval in 2010.CVac was developed by the biotechnology company Prima BioMed (Nasdaq: PBMD) through to Phase II clinical studies between 2001 and 2015.".
- CVac label "CVac".
- CVac sameAs m.012nggcq.
- CVac wasDerivedFrom CVac?oldid=669404037.
- CVac isPrimaryTopicOf CVac.